[go: up one dir, main page]

AU2003224313A1 - Mycobacterial antigens and uses thereof - Google Patents

Mycobacterial antigens and uses thereof

Info

Publication number
AU2003224313A1
AU2003224313A1 AU2003224313A AU2003224313A AU2003224313A1 AU 2003224313 A1 AU2003224313 A1 AU 2003224313A1 AU 2003224313 A AU2003224313 A AU 2003224313A AU 2003224313 A AU2003224313 A AU 2003224313A AU 2003224313 A1 AU2003224313 A1 AU 2003224313A1
Authority
AU
Australia
Prior art keywords
mycobacterial antigens
mycobacterial
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003224313A
Inventor
Paul Jason COCKLE
Stephen Vincent Gordon
Robert Glyn Hewinson
Hanns Martin Vordermeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Environment Food and Rural Affairs
Original Assignee
UK Secretary of State for Environment Food and Rural Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0209723A external-priority patent/GB0209723D0/en
Priority claimed from GB0209724A external-priority patent/GB0209724D0/en
Application filed by UK Secretary of State for Environment Food and Rural Affairs filed Critical UK Secretary of State for Environment Food and Rural Affairs
Publication of AU2003224313A1 publication Critical patent/AU2003224313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2003224313A 2002-04-27 2003-04-28 Mycobacterial antigens and uses thereof Abandoned AU2003224313A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0209724.4 2002-04-27
GB0209723A GB0209723D0 (en) 2002-04-27 2002-04-27 Diagnostic kit
GB0209723.6 2002-04-27
GB0209724A GB0209724D0 (en) 2002-04-27 2002-04-27 Vaccine
PCT/GB2003/001815 WO2003093307A2 (en) 2002-04-27 2003-04-28 Mycobacterial antigens and uses thereof

Publications (1)

Publication Number Publication Date
AU2003224313A1 true AU2003224313A1 (en) 2003-11-17

Family

ID=29404286

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003224313A Abandoned AU2003224313A1 (en) 2002-04-27 2003-04-28 Mycobacterial antigens and uses thereof

Country Status (2)

Country Link
AU (1) AU2003224313A1 (en)
WO (1) WO2003093307A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116102629A (en) * 2022-09-03 2023-05-12 武汉中纪生物科技有限公司 Mycobacterium tuberculosis T cell epitope polypeptide and application thereof

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4820489B2 (en) 1999-05-04 2011-11-24 ユニバーシティー、オブ、メディシン、アンド、デンティストリー、オブ、ニュージャージー Proteins expressed by Mycobacterium tuberculosis and not expressed by BCG, and their use as diagnostics and vaccines
WO2004099771A1 (en) * 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
WO2005054851A1 (en) * 2003-11-21 2005-06-16 Institut Pasteur Recombinant adenylate cyclase of bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
ITRM20040091A1 (en) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie QUICK IMMUNOLOGICAL TEST FOR DIAGNOSIS AND MONITORING OF TUBERCULAR INFECTION.
GB0406271D0 (en) * 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
CN100393876C (en) * 2004-05-11 2008-06-11 中国人民解放军第三○九医院 Mycobacterium tuberculosis proteins for tuberculosis diagnosis
CA2577597A1 (en) * 2004-08-19 2006-02-23 Proteome Systems Intellectual Property Pty Ltd. Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor
EP1674868A1 (en) * 2004-12-21 2006-06-28 Chang Gung University (a university of Taiwan) Method and device for detection of mycobacterium tuberculosis antigens in biological fluids
FR2873819B1 (en) * 2005-07-21 2009-07-10 Pasteur Institut DETECTION OF TUBERCULOSIS AND MYCOBACTERIUM TUBERCULOSIS INFECTION USING HBHA
US8486414B2 (en) * 2007-04-04 2013-07-16 Infectious Disease Research Institute Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereof
CN101661044B (en) * 2008-08-27 2013-10-16 复旦大学附属华山医院 Diagnostic reagent of tuberculosis and kit
CN102260328B (en) * 2010-07-15 2013-09-25 华中农业大学 Antigen Protein and Application of Mycobacterium Tuberculosis
CN104628833B (en) * 2015-01-23 2016-03-23 中国疾病预防控制中心传染病预防控制所 Antigen composition for immune detection of tuberculosis infected cells and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
JP4820489B2 (en) * 1999-05-04 2011-11-24 ユニバーシティー、オブ、メディシン、アンド、デンティストリー、オブ、ニュージャージー Proteins expressed by Mycobacterium tuberculosis and not expressed by BCG, and their use as diagnostics and vaccines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116102629A (en) * 2022-09-03 2023-05-12 武汉中纪生物科技有限公司 Mycobacterium tuberculosis T cell epitope polypeptide and application thereof
CN116102629B (en) * 2022-09-03 2023-09-08 武汉中纪生物科技有限公司 Mycobacterium tuberculosis T cell epitope polypeptide and application thereof

Also Published As

Publication number Publication date
WO2003093307A2 (en) 2003-11-13
WO2003093307A3 (en) 2004-03-18
WO2003093307A8 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
AU2003299778A1 (en) Antibodies against gpr64 and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2003289072A1 (en) Virus-removing bag and virus-removing method using the same
AU2003265576A1 (en) Corticosteroid conjugates and uses thereof
AU2003293644A1 (en) Moldings and preparation and uses thereof
AU2003232821A1 (en) Novel phospholipases and uses thereof
AU2003224313A1 (en) Mycobacterial antigens and uses thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003225054A1 (en) Toll-like receptor 11 and toll-like receptor 12
AU2003271183A1 (en) Block copolymer and application thereof
AU2003232075A1 (en) Modified t lymphocytes and uses therefor
AU2003205381A1 (en) Hpma-polyamine conjugates and uses therefore
IL166063A0 (en) Antibodies and uses thereof
AU2003283963A1 (en) Mage-c2 antigenic peptides and uses thereof
AU2003267361A1 (en) Orthopoxvirus antigens and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003249533A1 (en) Neoplasm specific antibodies and uses thereof
AU2003236166A1 (en) Fully-biodegradable film and its preparation process
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003263795A1 (en) Thioredoxin mutants and uses thereof
AU2001261534A1 (en) The meca-79 antigen and related methods
EP1694845B8 (en) Anticarcinoma antibodies and uses thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2002303093A1 (en) Mycobacterial vaccines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase